Browsing: Conditions

The arXiv:2312.15320GestaltMML paper was revised on July 6, 2026 and describes a Transformer-based multimodal model for rare genetic disease diagnosis. It combines frontal facial images, demographics and clinical text or HPO terms, and the authors report evaluations across 528 GestaltMatcher Database diseases plus several syndrome-specific cohorts. For practitioners, the important signal is that multimodal fusion…

ALEC is proud to recognize Sens. Donald Douglas, Stephen Meredith, Aaron Reed, and Shelley Funke Frommeyer, Reps. Ken Fleming and Bobby McCool, and Senate President Robert Stivers as ALEC Policy Champions for their successful effort to establish a framework for conducting clinical trials with ibogaine-based treatments in Kentucky

About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a mother who has these conditions has a higher risk of birth complications, overall poorer health, impaired bonding and nurturing of her infant, and a higher risk of death by suicide

A multi-millionaire who made it his life’s mission to defeat death has been diagnosed with an incurable autoimmune disease

Vertex PharmaceuticalsVRTX announced that it has agreed to acquire commercial-stage company Crinetics PharmaceuticalsCRNX. Per the terms, the large-cap biotech will acquire all outstanding shares of CRNX for $85 per share, valuing the deal at around $10 billion

Every year, millions of hospital stays involve people who use alcohol or drugs. In some cases, drug or alcohol use is the immediate reason for their hospitalization; in other cases, substance use is one of multiple contributing medical causes

On the Upper East Side, some residents on Monday were just learning that a cluster of Legionnaires’ disease, a severe form of bacterial pneumonia, had formed in the Manhattan neighborhood they call home

The Clayco Foundation has gifted $10 million to researchers at the Perelman School of Medicine at the University of Pennsylvania to help them to development a potential treatment for the ultra-rare disease retinal vasculopathy with cerebral leukoencephalopathy (RVCL)

This is a paid press release. Contact the press release distributor directly with any inquiries.

Existing data supports direct path to resubmission following constructive FDA engagement